Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond L Comenzo

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Cancer Management and Research|September 9, 2020
Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in TherapyDanai Dima, Joshua Dower, Raymond L Comenzo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2010
Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantationNeal Flomenberg, Raymond L Comenzo, Karin Badel, et al.
Blood Reviews|July 27, 2021
Smoldering multiple myeloma - Past, present, and futureHashim Mann, Vatsala Katiyar, Cindy Varga, et al.
Blood Reviews|June 7, 2019
Use of novel therapies in the treatment of light chain amyloidosisCindy Varga, Stephanie E Titus, Denis Toskic, et al.
Advances in Therapy|October 27, 2015
Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research ConsortiumIsabelle Lousada, Raymond L Comenzo, Heather Landau, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 22, 2013
Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typingEsha Kaul, Monika Pilichowska, Mithila Vullaganti, et al.
Blood|April 12, 2014
One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stressPing Zhou, Xun Ma, Lakshmanan Iyer, et al.
Blood|January 28, 2006
Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteinsRaymond L Comenzo, Ping Zhou, Martin Fleisher, et al.
Journal of Neuro-Oncology|June 27, 2003
Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapyBernardo Liberato, Adrienne Riethmuller, Raymond L Comenzo, et al.
CA: a Cancer Journal for Clinicians|June 8, 2026
Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updatesXia Wu, Heather Landau, Jennifer E Liu, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Cancer Management and Research|September 9, 2020
Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in TherapyDanai Dima, Joshua Dower, Raymond L Comenzo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2010
Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantationNeal Flomenberg, Raymond L Comenzo, Karin Badel, et al.
Blood Reviews|July 27, 2021
Smoldering multiple myeloma - Past, present, and futureHashim Mann, Vatsala Katiyar, Cindy Varga, et al.
Blood Reviews|June 7, 2019
Use of novel therapies in the treatment of light chain amyloidosisCindy Varga, Stephanie E Titus, Denis Toskic, et al.
Advances in Therapy|October 27, 2015
Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research ConsortiumIsabelle Lousada, Raymond L Comenzo, Heather Landau, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 22, 2013
Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typingEsha Kaul, Monika Pilichowska, Mithila Vullaganti, et al.
Blood|April 12, 2014
One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stressPing Zhou, Xun Ma, Lakshmanan Iyer, et al.
Blood|January 28, 2006
Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteinsRaymond L Comenzo, Ping Zhou, Martin Fleisher, et al.
Journal of Neuro-Oncology|June 27, 2003
Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapyBernardo Liberato, Adrienne Riethmuller, Raymond L Comenzo, et al.
CA: a Cancer Journal for Clinicians|June 8, 2026
Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updatesXia Wu, Heather Landau, Jennifer E Liu, et al.
Pageof 9